vaccines

Why Pfizer and BioNTech Stocks Zoomed Higher Friday
Why Pfizer and BioNTech Stocks Zoomed Higher Friday
Motley Fool
COVID-19
vaccines
Pfizer
BioNTech
Flag link:
Flu, Covid vaccination rates decline, as U.S. health officials make new push for inoculations
Flu, Covid vaccination rates decline, as U.S. health officials make new push for inoculations
Stat
vaccines
COVID-19
Flu
Flag link:
Gritstone bio wins $433 million US contract for COVID vaccine study
Gritstone bio wins $433 million US contract for COVID vaccine study
Reuters
Gritstone Bio
vaccines
COVID-19
MRNA
federal contracts
Flag link:
Inside Bavarian Nordic’s late-stage stumbles — and drive to become a vaccine giant
Inside Bavarian Nordic’s late-stage stumbles — and drive to become a vaccine giant
Pharma Voice
Bavarian Nordic
vaccines
RSV
COVID-19
Paul Chaplin
Flag link:
mRNA Vaccine Manufacturing Comes to Africa
mRNA Vaccine Manufacturing Comes to Africa
BioSpace
BioNTech
MRNA
vaccines
drug manufacturing
Africa
Rwanda
Flag link:
Rollout of Covid vaccines is bumpy, but not unexpected, experts say
Rollout of Covid vaccines is bumpy, but not unexpected, experts say
Stat
vaccines
boosters
COVID-19
Flag link:
CDC recommends RSV vaccine in late pregnancy to protect newborns
CDC recommends RSV vaccine in late pregnancy to protect newborns
NPR
Pfizer
CDC
pregnancy
RSV
Abryvso
vaccines
Flag link:
Mendus shows early comparability data for its universal cancer vaccine
Mendus shows early comparability data for its universal cancer vaccine
Clinical Trials Arena
Mendus
vididencel
AML
ovarian cancer
vaccines
Flag link:
Europe expects to decide on Novavax's COVID vaccine in October
Europe expects to decide on Novavax's COVID vaccine in October
Reuters
Europe
EMA
Novavax
vaccines
COVID-19
Flag link:
BioNTech wins up to $90 mln in funding for mpox vaccine development
BioNTech wins up to $90 mln in funding for mpox vaccine development
Yahoo/Reuters
BioNTech
mpox
vaccines
funding
Flag link:
Pfizer forecasts 24% COVID vaccination rate in US this year
Pfizer forecasts 24% COVID vaccination rate in US this year
Yahoo/Reuters
Pfizer
vaccines
COVID-19
Flag link:
New RSV vaccines can be powerful tools, but rollout poses test
New RSV vaccines can be powerful tools, but rollout poses test
BioPharma Dive
vaccines
RSV
Flag link:
NIH begins human trials of 'universal' flu vaccine
NIH begins human trials of 'universal' flu vaccine
Yahoo/Reuters
NIH
clinical trials
vaccines
universal flu vaccine
FluMos-v2
Flag link:
Vaxess announces $9 million in funding for mRNA vaccine patch
Vaxess announces $9 million in funding for mRNA vaccine patch
Biopharma Reporter
Vaxess Technologies
vaccine patches
funding
MRNA
vaccines
Flag link:
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
CNBC
Moderna Therapeutics
vaccines
Flu
flu vaccines
clinical trials
Flag link:
Why COVID Vaccine Demand Might Not Be That Strong
Why COVID Vaccine Demand Might Not Be That Strong
Motley Fool
COVID-19
vaccines
boosters
Flag link:
Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?
Updated Covid-19 Vaccines Are Here: Will They Help Protect Against Long Covid?
Forbes
FDA
COVID-19
vaccines
boosters
Pfizer
Moderna Therapeutics
BioNTech
Flag link:
Why the CDC has recommended new COVID boosters for all
Why the CDC has recommended new COVID boosters for all
Medical Marketing and Media
CDC
COVID-19
vaccines
boosters
Flag link:
CDC recommends updated Covid vaccines for everyone 6 months and older
CDC recommends updated Covid vaccines for everyone 6 months and older
Stat
CDC
vaccines
COVID-19
Flag link:
Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines
Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines
Fierce Pharma
Pfizer
BioNTech
Moderna Therapeutics
FDA
COVID-19
vaccines
Flag link:

Pages